J&J to spin off consumer biz within two years; Biden nominates Califf as FDA chief
After a gap of a week, Phispers is back with reports of some big developments in the world of pharmaceuticals. The biggest news...
Impressions : 1863
MI5 says Russian spies stole design of Astra-Oxford jab; Sanofi, GSK, Pfizer, BI can’t escape Zantac lawsuits
This week, we bring you news from the UK, where security services have alleged that Russian spies stole the blueprint of AstraZ...
Impressions : 2161
BMS buys biopharma firm MyoKardia for US$ 13.1 billion; Concerns emerge over quality of acetazolamide
This week, Phispers has more updates on Covid-19 vaccines and therapies.
In the US, President Donald Trump contracted the vir...
Impressions : 88818
Sanofi overhauls executive committee; FDA recalls metformin due to unacceptable levels of NDMA impurity
This week, Phispers brings news on various developments across the world as a result of the Covid-19 pandemic.
While US Presi...
Impressions : 89399
Trump admin wants to pull global supply chains out of China; FDA okays remdesivir for emergency use
This week, Phispers has news on remdesivir, Gilead’s investigational antiviral drug.
The USFDA has issued an emergency ...
Impressions : 67102
FDA highlights data-integrity concerns at Pfizer’s India unit; FDA requests removal of all ranitidine products
This week, N-nitrosodimethylamine (NDMA) is back in news as the FDA requests manufacturers to withdraw ranitidine from the mark...
Impressions : 3658
Merck spins off slow-growing drugs into US$ 6.5 billion firm; Aurobindo’s facility gets classified as OAI
This week, Phispers brings you news on Merck as the drugmaker spun off its slowing-growing drugs into a new drug company with U...
Impressions : 3511
After sartans, diabetes drug metformin being tested for cancer causing impurities; FDA’s overseas inspections drop
This week in Phispers, we bring you the major announcements made by Sanofi’s new CEO Paul Hudson at its strategy meet.
...
Impressions : 2747
EMA raises NDMA impurity concerns in diabetes drug made by Hetero; shareholder revolt rocks Bayer
This week, there is news on EMA telling companies using certain reagents to make diabetes drug — pioglitazone &mdash...
Impressions : 3995
Apotex explores sale; Perrigo looks at selling prescription business; Takeda puts Latam biz on the block
This week, Phispers has good news for patients on sartan drugs.
For the first time since nitrosamine impurities were discovere...
Impressions : 7468
FDA proposes limits on ‘sartan’ nitrosamine impurities; Text messages add new twist to US generic price fixing litigation
In our final Phispers of 2018, we bring you news on how the big pharmaceutical companies in the US plan to ring in the new year...
Impressions : 5095
Bayer to cut 12,000 jobs; GSK buys cancer drugmaker Tesaro for US$ 5 billion
This week, Phispers has news on German drug major Bayer, which has drawn out a revamp plan that includes plans to slash 12,000 ...
Impressions : 2818
Aurobindo’s sartan banned in Europe; Dr. Reddy’s cost optimization drive continues, sells off another site
This week, Phispers brings you news from Dr. Reddy’s Laboratories in India which is divesting its API plant in Hyderabad ...
Impressions : 3877
Novartis seeks to clean image, links employee bonuses to ethics; EMA, FDA probe new impurity in valsartan
This week, Phispers brings you the latest on the valsartan contamination. FDA and EMA have found the presence of an additional ...
Impressions : 2765
FDA, EMA highlight more concerns over APIs from China; FDA slams Apotex’s India operations
This week, Phispers brings you more news on quality problems with active pharmaceutical ingredients from China. The FDA commiss...
Impressions : 4985
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.